Premium
Immune potential of allogeneic equine induced pluripotent stem cells
Author(s) -
Aguiar C.,
Theoret C.,
Smith O.,
Segura M.,
Lemire P.,
Smith L. C.
Publication year - 2015
Publication title -
equine veterinary journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.82
H-Index - 87
eISSN - 2042-3306
pISSN - 0425-1644
DOI - 10.1111/evj.12345
Subject(s) - transplantation , major histocompatibility complex , antigenicity , induced pluripotent stem cell , alloimmunity , immune system , immunology , biology , miniature swine , peripheral blood mononuclear cell , in vivo , antigen , in vitro , medicine , embryonic stem cell , gene , biochemistry , microbiology and biotechnology
Summary Reasons for performing study Induced pluripotent stem cells ( iPSC ) have brought immense hope to cellular therapy and regenerative medicine. However, the antigenicity of iPSC has not been well documented and remains a hurdle for clinical applications. Expression of major histocompatibility complex ( MHC ) molecules by human and murine iPSC is downregulated, making these cells potentially safe for transplantation. No such data are available for any large animal model. Objectives To measure expression of MHC molecules on equine iPSC ( eiPSC ) and describe their antigenicity using intradermal testing. The hypothesis was that allogeneic eiPSC weakly express MHC molecules and would not elicit a rejection response when injected intradermally. Study design Experimental study involving both in vitro and in vivo components. Methods Two green fluorescent protein‐expressing eiPSC lines were analysed by flow cytometry for MHC expression. One line was then transplanted intradermally, along with appropriate controls, into 2 unrelated experimental horses. Blood was collected pre‐ and 7 days post transplantation. The wheals formed at the sites of injection were measured at regular intervals beginning at 0.25 h until 4 weeks. Tissue samples of the injected sites were obtained at 2, 3, 7 and 30 days post transplantation and analysed by histopathology and immunofluorescence. Results Both eiPSC lines weakly expressed MHC molecules. eiPSC were detectable up to 7 days following allogeneic transplantation and elicited no apparent systemic response. Injection of eiPSC caused small wheal formation at the skin surface. Skin sections revealed CD 4 + and CD 8 + mononuclear cells up to 30 days post transplantation. Conclusions These data suggest that while transplantation of allogeneic eiPSC elicits a moderate cellular response, it does not cause acute rejection. The feasibility of banking allogeneic iPSC for regenerative medicine applications should be explored.